Drug usage and costs of inpatients with ischemic stroke in Karamay Central Hospital in 2014_Chinese Journal of Evidence-Based Medicine

Authors：

WANG Guotuan ¹ , YU Jiajie ² ,  WU Min ¹ ,  LI Youping ² , ZHANG Weidong ¹ , XU Ting ³ , KUANG Liping ¹ , LU Jing ³ , FANG Yiqing ¹ , SUN Xin ² , SU Guanyue ²

1. Department of Pharmacy, Karamay Central Hospital, Karamay, 834000, P.R.China;
2. Chinese Evidence-Based Medicine Center, West China Hospital, Sichuan University, Chengdu, 610041, P.R.China;
3. Department of Pharmacy, West China Hospital, Sichuan University, Chengdu, 610041, P.R.China;

Corresponding?author：

WU Min, Email: 1109637804@qq.com.cn; LI Youping, Email: yzmylab@hotmail.com

Keywords：

Inpatient; Stroke; Evidence-based pharmacy; Rational drug use

DOI：

10.7507/1672-2531.201610065

Video：

Export PDF Favorites Scan Get Citation

Abstract Full text Figures/Tables Video References Cited by

Objective To investigate drug usage and costs of ischemic stroke inpatients in Karamay Central Hospital in 2014 and to provide evidence and reference for evidence-based pharmacy study of single disease in circulation system. Methods The information of drug use and expenditure of ischemic stroke inpatients were collected from the hspital information system (HIS). We analyzed the data including frequency, proportion and cumulative proportion by Excel 2007 software. Results We included 522 ischemic stroke inpatients in Karamay Central Hospital in 2014, the average age was 67.58±13.27 years old. Forty three kinds of drugs were used for ischemic stroke therapy. The total expenditure of drugs was 10.94 million and 1 807.99 yuan per person. The most used drugs were for symptomatic treatment which included 18 kinds of drugs. The using frequency of aspirin, edaravone, oxircetan were the highest. The secondary prevention medicines included 23 kinds of drugs. The anti-hypertensive, lipid-lowering and hypoglycemic agents were prescribed mostly. Traditional Chinese medicines were prescribed 234 times, and the injection Ligustrazine with glucose was the most used drug. Conclusion The mainly drugs for treatment of ischemia stroke inpatients in Karamay Central Hospital in 2014 are aspirin, edaravone and oxircetan; while the expenditure of clopidogrel and oxiracetam were the highest.

Citation： WANG Guotuan, YU Jiajie, WU Min, LI Youping, ZHANG Weidong, XU Ting, KUANG Liping, LU Jing, FANG Yiqing, SUN Xin, SU Guanyue. Drug usage and costs of inpatients with ischemic stroke in Karamay Central Hospital in 2014. Chinese Journal of Evidence-Based Medicine, 2017, 17(8): 895-898. doi: 10.7507/1672-2531.201610065 Copy

1.	趙澎, 胡微, 烏尤圖, 等. 神經保護劑的應用與評價. 中華神經外科疾病研究雜志, 2015, 14(2): 188-189.
2.	Adams HP Jr, del Zoppo G, José B, et al. 2015 American Heart Association/American Stroke Association focused update of the 2013 guidelines for the early management of adults with ischemic stroke. Stroke, 2015, 46(11): 3020-3039.
3.	中華醫學會神經病學分會腦血管病學組. 中國急性缺血性腦卒中診治指南 2014 版. 中華神經科雜志, 2015, 48(4): 246-257.
4.	Walter NK, Bruce O, Henry RB, et al. Guidelines for the prevention of stroke in patients with stroke and transient ischemic attack. Stroke, 2014, 45(7): 2160-2236.
5.	Venketasubramanian N, Pwee KH, Chen CP, et al. Singapore ministry of health clinical practice guidelines on stroke and transient ischemic attacks. Int J Stroke, 2011, 6(3): 251-258.
6.	Adams HP Jr, del Zoppo G, Alberts MJ, et al. Guidelines for the early management of adults with ischemic stroke. Stroke, 2007, 38(5): 1655-1711.
7.	杜官林, 榮陽, 賈韻楠. 腦梗死的二級預防疾病防控. 疾病防控, 2009, 16(7): 122-123.
8.	中華醫學會神經病學分會腦血管病學組缺血性腦卒中二級預防指南撰寫組. 中國缺血性腦卒中和短暫性腦缺血發作二級預防指南. 中國臨床醫生, 2011, 39(11): 68-74.

1. 趙澎, 胡微, 烏尤圖, 等. 神經保護劑的應用與評價. 中華神經外科疾病研究雜志, 2015, 14(2): 188-189.
2. Adams HP Jr, del Zoppo G, José B, et al. 2015 American Heart Association/American Stroke Association focused update of the 2013 guidelines for the early management of adults with ischemic stroke. Stroke, 2015, 46(11): 3020-3039.
3. 中華醫學會神經病學分會腦血管病學組. 中國急性缺血性腦卒中診治指南 2014 版. 中華神經科雜志, 2015, 48(4): 246-257.
4. Walter NK, Bruce O, Henry RB, et al. Guidelines for the prevention of stroke in patients with stroke and transient ischemic attack. Stroke, 2014, 45(7): 2160-2236.
5. Venketasubramanian N, Pwee KH, Chen CP, et al. Singapore ministry of health clinical practice guidelines on stroke and transient ischemic attacks. Int J Stroke, 2011, 6(3): 251-258.
6. Adams HP Jr, del Zoppo G, Alberts MJ, et al. Guidelines for the early management of adults with ischemic stroke. Stroke, 2007, 38(5): 1655-1711.
7. 杜官林, 榮陽, 賈韻楠. 腦梗死的二級預防疾病防控. 疾病防控, 2009, 16(7): 122-123.
8. 中華醫學會神經病學分會腦血管病學組缺血性腦卒中二級預防指南撰寫組. 中國缺血性腦卒中和短暫性腦缺血發作二級預防指南. 中國臨床醫生, 2011, 39(11): 68-74.

Chinese Journal of Evidence-Based Medicine

Drug usage and costs of inpatients with ischemic stroke in Karamay Central Hospital in 2014

Abstract Full text Figures/Tables Video References Cited by

Previous Article

Next Article

Format

Content